Site icon Vero News

A Lesser-Known Neurologic Condition Related to Traumatic Brain Injury: What to Know

(BPT) – Approximately 2.3 million people in the U.S. have suffered from a traumatic brain injury (TBI).1 According to a study published in Advances in Therapy which included 326 TBI patients, nearly half (48.2 percent) had symptoms suggestive of a neurologic condition known as PseudoBulbar Affect (PBA), which can occur secondary to neurologic conditions such as TBI.1 Based on this prevalence data, over 1 million people in the U.S. who have had a TBI may also have PBA.1

TBI affects everyone differently. Some experience PBA symptoms of frequent, uncontrollable crying and/or laughing very soon after their injury. While for others, these symptoms may not be recognized until some months after their TBI during the recovery process. Some never experience PBA at all.2 If you have suffered from a TBI and have experienced such symptoms that are impacting your life, talk to your doctor and describe these symptoms, as this could be PBA.

What Is PBA?

PBA is a condition that results in sudden, frequent and uncontrollable episodes of crying and/or laughing that don’t match how you feel.2 It is thought to affect about two million people in the U.S. who suffer from common neurologic diseases or traumatic brain injuries, and can affect men and women.1

PBA is a distinct condition that can happen in people secondary to a core neurologic condition such as TBI, stroke, Alzheimer’s disease (AD) and dementia, multiple sclerosis (MS), Parkinson’s or amyotrophic lateral sclerosis (ALS). In people with these conditions, the signals that tell a person’s body when or how much to cry or laugh are disrupted. These sudden episodes are often exaggerated (more intense or lasting longer than expected) or mismatched (not fitting the situation).2

PBA Is Not Depression

Although symptoms of PBA may be mischaracterized as depression, PBA and depression are two separate conditions, and can be independently diagnosed. These conditions can coexist and are both treatable.3

Treating PBA

There is a medication called NUEDEXTA® (dextromethorphan hydrobromide and quinidine sulfate) that is the first and only FDA-approved treatment for PBA.4

In a 12-week clinical trial, NUEDEXTA was proven to significantly reduce PBA episodes. Compared to baseline, patients had an average of 44 percent fewer PBA episodes after the first week of taking NUEDEXTA (versus 19 percent taking placebo). After completing 12 weeks of therapy, patients had 82 percent fewer episodes compared to baseline (versus 45 percent taking placebo). Additionally, 51 percent of patients were completely free of PBA episodes during the final two weeks of the study (versus 29 percent taking placebo).5,6

Talk to Your Doctor

If you or someone you care for has a brain injury or neurologic condition and experiences frequent, unexpected, and uncontrollable episodes of crying and/or laughing that do not match how the person feels, ask your doctor if it could be PBA.

In the meantime, you can take a short quiz at www.nuedexta.com. Your answers may help you start a conversation with your doctor.7

What is NUEDEXTA® approved for?

Important Safety Information

Before you take NUEDEXTA, tell your doctor:

While taking NUEDEXTA, call your doctor right away:

The most common side effects of NUEDEXTA are diarrhea, dizziness, cough, vomiting, weakness, and swelling of feet and ankles. This is not a complete list of side effects. Tell your doctor about any side effect that bothers you or does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 800-FDA-1088.

IMPORTANT FACTS

ABOUT NUEDEXTA

DO NOT TAKE NUEDEXTA IF YOU

If you have certain heart conditions or are taking certain medicines, your doctor may test your heart rhythm (heartbeats) before you start NUEDEXTA.

NUEDEXTA MAY CAUSE SERIOUS SIDE EFFECTS

POSSIBLE COMMON SIDE EFFECTS OF NUEDEXTA

The most common side effects in patients taking NUEDEXTA were diarrhea, dizziness, cough, vomiting, weakness and swelling of feet and ankles.

TAKING NUEDEXTA ALONG WITH OTHER MEDICATIONS

ADDITIONAL IMPORTANT INFORMATION

NEED MORE INFORMATION?

This information about NUEDEXTA is important but is not complete. To learn more:

NEED PRESCRIPTION ASSISTANCE?

©2017 Avanir Pharmaceuticals, Inc. All rights reserved.

NUEDEXTA is a registered trademark of Avanir Pharmaceuticals, Inc.

NUE-0543-OTH-0317
1 Work SS, Colamonico JA, Bradley WG, Kaye RE. Pseudobulbar affect: an under-recognized and under-treated neurological disorder. Adv Ther. 2011;28:586–601. Prevalence and percentage based on CNS-LS =13. Two million based on CNS-LS =21.

2 What is PBA? NUEDEXTA.com. https://www.nuedexta.com/what-is-pba. Accessed January 25, 2017.

3 How is PBA different from Depression? NUEDEXTA.com. https://www.nuedexta.com/pba-vs-depression. Accessed January 25, 2017.

4 How NUEDEXTA can help. NUEDEXTA.com. https://www.nuedexta.com/treating-pba/how-nuedexta-can-help. Accessed January 25, 2017.

5 Results vs baseline from a 12-week, double-blind, clinical study that evaluated the safety and efficacy of NUEDEXTA (N=107) for the treatment of PBA in ALS and MS patients. Patients on placebo (N=109) experienced a 19% reduction in PBA episodes at Week 1 and a 45% reduction in PBA episodes at Week 12 compared to baseline.

6 Pioro EP, Brooks BR, Cummings J, et al. Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol. 2010;68:693-702.

7 Do you have PBA? NUEDEXTA.com. https://www.nuedexta.com/do-you-have-pba. Accessed January 25, 2017.

Exit mobile version